Let's Talk

Learn more about Veterinary Diagnostics Market Analysis

Overview

The majority of animal health companies sell drugs for cats and dogs. The largest sub-segment of the animal health industry is the pet antiparasitics space. Other drugs include therapeutics for pain, cancer and allergies.

CI_0425_Birds-arrow

Key Benefits

Animal Health

In recent years, animal health has seen the introduction of multiple blockbuster drugs (over $100 million in annual sales) for cats and dogs.

Generic Competition

There is limited generic competition in the animal health sector, meaning brands have significant longevity.

Zoetis

Zoetis made more annual sales in the companion animal sector than the livestock market for the first time in 2019.

Recent new blockbuster pharmaceuticals include Apoquel, Simparica and Cytopoint from Zoetis.

Millennials

Many pet owners – especially millennials – are becoming increasingly interested in pet health and stimulating the ‘humanization’ of companion animals.

Unlock new opportunities in the global animal health sector

Key Themes Affecting The Animal Pharmaceuticals Market

Many animal health companies, from multinationals to start-ups, are focusing on developing new pet drugs. Zoetis has shown recently there is demand for new pet treatments in dermatology and this has stimulated increased research and development in pet health (pain, cancer, allergies, anxiety etc). Spending on pets is increasing in developed markets and China as well. As well as internal R&D, animal health companies are licensing technologies from the human pharma sector and trying to translate this innovation to pets. One key area of innovation is monoclonal antibodies (mAbs). In human pharmaceuticals, most top-selling drugs are mAbs. In animal health, there is only one mAb on sale. Companies such as Zoetis, Kindred Biosciences and PetMedix are now aiming to bring more mAbs to animal health.

blog-Chemical-Tech-transformation-476146627

Solutions

Agribusiness Blogs & Analysis

Data & Distribution

Get the edge in today’s global markets with our Essential Intelligence® delivered through the providers and platforms which suit you.

API Solutions

Cloud

Data Feed

Desktop & Mobile

Why Choose Us?

Unparalleled Experience

For 100+ years, we've delivered Platts price assessments for physical and forward markets. Customers count on us for news, pricing, and analytics, ensuring transparent, efficient markets for confident decisions.

Benchmark Prices

With 250+ Platts benchmarks, we're the industry standard for pricing negotiations and contracts. Our proven credibility in market transparency spans established and emerging markets.

Robust Methodology

Our robust methodology guarantees data integrity with stringent quality controls, diverse sources, and adherence to strict guidelines and IOSCO principles. We openly publish methodologies and price assessments to foster trust.

Data Your Way

Gain access to our essential intelligence direct and from multiple providers – from the established to the cutting edge – all via multiple platforms that can give you a decisive edge in today's global markets.

Pricing Experts

Globally, our extensive pricing experts, dedicated to each commodity ensure that pricing and methodology accuracy and that reflect the nuances and complexities of the markets, offering invaluable insights to clients.

Independent Source

Platts offers an independent and unbiased view. Our commitment to impartiality ensures that our assessments and insights are trusted by market participants.

Contact Sales

Interested in this product?

Complete the form and a team member will reach out to discuss how our solutions can support you.

Clicking on the confirm button means that you acknowledge that you have read and agree to our Terms of Use and Privacy Policy, including transfer of your personal information outside of the jurisdiction in which you are located .